The U.S. Securities and Exchange Commission (SEC) has requested that issuers of exchange-traded funds related to XRP, Litecoin (LTC), Solana (SOL), Cardano (ADA), and Dogecoin (DOGE) withdraw pending 19b-4 filings. Journalist Eleanor Terrett reported the change, stating that the recent approval of generic listing standards by the regulator eliminates the need for individual filings, thereby […]The U.S. Securities and Exchange Commission (SEC) has requested that issuers of exchange-traded funds related to XRP, Litecoin (LTC), Solana (SOL), Cardano (ADA), and Dogecoin (DOGE) withdraw pending 19b-4 filings. Journalist Eleanor Terrett reported the change, stating that the recent approval of generic listing standards by the regulator eliminates the need for individual filings, thereby […]

SEC asked issuers to withdraw XRP, LTC, SOL, ADA, and DOGE ETF filings under new listing rules

2025/09/30 02:13
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

The U.S. Securities and Exchange Commission (SEC) has requested that issuers of exchange-traded funds related to XRP, Litecoin (LTC), Solana (SOL), Cardano (ADA), and Dogecoin (DOGE) withdraw pending 19b-4 filings.

Journalist Eleanor Terrett reported the change, stating that the recent approval of generic listing standards by the regulator eliminates the need for individual filings, thereby clearing the path to approval.

These standards are a replacement for the old case-by-case review under Section 19(b) of the Securities Exchange Act. Instead of waiting up to 240 days for a decision, issuers can now rely on predetermined requirements. Exchanges that meet these criteria can proceed directly to the listing process, significantly reducing the overall process. Terrett stressed that this development is a sign that the new framework is working as it is supposed to.

Faster approvals and simplified procedures

Under the new rules, commodity-based ETFs, including those that are linked to cryptocurrencies, can be listed provided they meet eligibility criteria such as having futures contracts under the jurisdiction of the Commodity Futures Trading Commission (CFTC). With this model, the SEC effectively minimizes delays associated with filing reviews and with withdrawal notices. 

The final SEC deadlines for some crypto ETF decisions under the 19b-4 process start this month, including for XRP, SOL, and Dogecoin. Crypto issuers such as Fidelity and Franklin Templeton are now modifying their applications accordingly. Additionally, the Issuers are expected to start taking their older submissions back within days.

According to market analysts, the generic listing framework will spur a wave of new spot cryptocurrency ETFs. Unlike earlier filings, which required scrutiny by an individual, the new process brings efficiency while ensuring compliance protection.

Political risks cloud the timeline

Even with the streamlined system, there is uncertainty. Bloomberg analyst James Seyffart cited the impending government shutdown in the US as a possible roadblock. This rule’s effective date falls within the window of time during which the SEC may begin accepting applications for the rule’s waivers, raising questions about staffing and decision-making capacity.

Seyffart’s colleague Eric Balchunas added that it’s not clear yet when these ETFs will launch. With prospectuses being filed months ahead of time, the timing of approval now hinges on the Division of Corporation Finance of the SEC, not statutory deadlines.

To add to further uncertainty in the near term, Polymarket’s prediction market signals a 69% likelihood of a shutdown by October 1. The budget negotiations have already held up the discussion of the CLARITY Act, another crypto-related bill.

Want your project in front of crypto’s top minds? Feature it in our next industry report, where data meets impact.

Market Opportunity
XRP Logo
XRP Price(XRP)
$1.4192
$1.4192$1.4192
+0.18%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

a16z Targets $2 Billion Crypto Fund as Venture Capital Eyes Blockchain Recovery

a16z Targets $2 Billion Crypto Fund as Venture Capital Eyes Blockchain Recovery

Andreessen Horowitz’s crypto division, a16z crypto, is reportedly running $2 billion for its fifth crypto investment fund. This move from a firm is happening when
Share
Thenewscrypto2026/03/05 20:29
ArtGis Finance Partners with MetaXR to Expand its DeFi Offerings in the Metaverse

ArtGis Finance Partners with MetaXR to Expand its DeFi Offerings in the Metaverse

By using this collaboration, ArtGis utilizes MetaXR’s infrastructure to widen access to its assets and enable its customers to interact with the metaverse.
Share
Blockchainreporter2025/09/18 00:07
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11